Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Study of an Implantable Miniature Telescope in Patients With With End-Stage AMD
This study is currently recruiting participants.
Verified by VisionCare Ophthalmic Technologies, Inc., May 2008
Sponsored by: VisionCare Ophthalmic Technologies, Inc.
Information provided by: VisionCare Ophthalmic Technologies, Inc.
ClinicalTrials.gov Identifier: NCT00555165
  Purpose

Evaluation of pre and post−implantation management of patients with end−stage age−related macular degeneration (AMD) who have been implanted with the implantable telescope (IMT) under CE Mark indicated use. This study is designed to evaluate in particular the optimal parameters for patient selection for use of this device in routine clinical practice.


Condition Intervention
End Stage Macular Degeneration
Device: Telescope prosthesis

Genetics Home Reference related topics: X-linked juvenile retinoschisis
MedlinePlus related topics: Macular Degeneration
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Open Label, Single Group Assignment
Official Title: A Prospective Multicenter Clinical Study of the Implantable Miniature Telescope* in Patients With Central Vision Impairment Associated With AMD: IMT-UK Protocol (*IMT by Dr. Isaac Lipshitz)

Further study details as provided by VisionCare Ophthalmic Technologies, Inc.:

Primary Outcome Measures:
  • Best-Corrected Visual Acuity [ Time Frame: 1 year ]

Secondary Outcome Measures:
  • Quality of Life [ Time Frame: 1 year ]

Estimated Enrollment: 75
Study Start Date: November 2007
Estimated Study Completion Date: July 2009
Arms Assigned Interventions
I: Experimental Device: Telescope prosthesis
Monocular implantation of the telescope prosthesis after cataract extraction

  Eligibility

Ages Eligible for Study:   55 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

CE Mark approved indication of use which includes

  • At least 55 years of age
  • Bilateral visual impairment due to geographic atrophy or disciform scars
  • Evidence of cataract

Exclusion Criteria:

  • Active CNV (or 'wet' AMD)
  • Prior cataract or refractive surgery in the study eye
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00555165

Contacts
Contact: Carole Schreier +1 4088729393 carole@visioncareinc.net
Contact: Chet Kumar, DPT +1 4088729393

Locations
United Kingdom
Royal Hospitals, Belfast Health & Social Care Trust Recruiting
Belfast, United Kingdom, BT12 6BA
Contact: Murali R Upendran            
Principal Investigator: Giuliana Silvestri, MD FRCS            
Moorfields Eye Hospital NHS Trust Recruiting
London, United Kingdom, EC1V 1JN
Contact: Tina Burman            
Principal Investigator: Mark Wilkins, MD FRCOphth            
Sub-Investigator: Adnan Tufail, MD MRCOphth            
King's College Hospital NHS Trust Recruiting
London, United Kingdom, SE5 9RS
Contact: Irene Kimm            
Principal Investigator: Victor Chong, MD, FRCOphth            
Principal Investigator: Emma Hollick, MD, FRCOphth            
Sponsors and Collaborators
VisionCare Ophthalmic Technologies, Inc.
Investigators
Principal Investigator: Giuliana Silvestri, MD FRCP FRCS Royal Hospitals, Belfast Health & Social Care Trust
  More Information

Study ID Numbers: IMT-UK
Study First Received: November 5, 2007
Last Updated: May 6, 2008
ClinicalTrials.gov Identifier: NCT00555165  
Health Authority: United Kingdom: Research Ethics Committee

Keywords provided by VisionCare Ophthalmic Technologies, Inc.:
Macular Degeneration
Visual Impairment
Quality of Life
Implantable Telescope

Study placed in the following topic categories:
Eye Diseases
Quality of Life
Retinal Degeneration
Macular Degeneration
Retinal Diseases
Vision, Low
Retinal degeneration

ClinicalTrials.gov processed this record on January 15, 2009